-

Company Profile for Guided Therapeutics, Inc.

--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP) has developed a rapid and painless testing platform for the early detection of disease based on its patented biophotonic technology that utilizes light to detect disease at the cellular level. The company’s first product, LuViva™, is a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial, with women at risk for cervical disease, LuViva was able to detect cervical cancer up to two years earlier than conventional tests. LuViva is designed to provide an objective result at the point-of-care, thereby improving the management of cervical disease: www.guidedinc.com.

Company:

Guided Therapeutics, Inc.

 

 

Headquarters Address:

5835 Peachtree Corners East

 

Suite B

 

Norcross, GA 30092

 

 

Main Telephone:

770-242-8723

 

 

Website:

www.guidedinc.com

 

 

Ticker/ISIN:

GTHP(OTCQB)/US40171F1057

 

 

Type of Organization:

Public

 

 

Industry:

Medical Devices

 

 

Key Executives:

CEO: Gene Cartwright

 

COO: Mark Faupel

 

 

Investor Relations

 

Contact:

Mark Faupel

Phone:

770-242-8723

Email:

mfaupel@guidedinc.com

 

Industry:

Guided Therapeutics, Inc.

OTCQB:GTHP
Release Summary
Company Profile for Guided Therapeutics, Inc.
Release Versions
English
Hashtags
#cervicalcancer
More News From Guided Therapeutics, Inc.

Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP) announced today the completion of the clinical trial for marketing and sales approval of the Company’s LuViva Advanced Cervical Scan by the Chinese National Medical Products Administration (NMPA). The study, which included approximately 450 women, was conducted at four prestigious medical institutions, including Shandong University, Fudan University and Peking University. The study was led by Professor Dr. Kong Bei...

Guided Therapeutics Provides Update on Start of Clinical Trial for US FDA Approval

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. or the “Company” (OTCQB: GTHP), the maker of LuViva, a rapid and painless cervical cancer detection system based on the Company’s patented biophotonic technology, provided an update regarding the start of its pivotal clinical trial. The results of this clinical study will be used to support the Company’s application for U.S. FDA approval. The clinics involved in the study represent a mix of academic and community practices as we...

Guided Therapeutics Announces New Agreement and Purchase Orders from Shandong Yaohua Medical Instrument Corporation

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics Announces New Agreement and Purchase Orders from Shandong Yaohua Medical Instrument Corporation...
Back to Newsroom